ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report)’s share price passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $113.47 and traded as high as $118.03. ProShares Ultra Nasdaq Biotechnology shares last traded at $117.7660, with a volume of 5,877 shares traded.
ProShares Ultra Nasdaq Biotechnology Trading Up 4.5%
The firm has a market capitalization of $101.28 million, a price-to-earnings ratio of 20.68 and a beta of 1.25. The company has a fifty day moving average price of $113.47 and a 200-day moving average price of $95.82.
ProShares Ultra Nasdaq Biotechnology’s stock is scheduled to split on Thursday, November 19th. The 2-1 split was recently announced. The newly created shares will be distributed to shareholders after the market closes on Wednesday, November 18th.
Institutional Inflows and Outflows
About ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.
See Also
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?
- MarketBeat Week in Review – 11/2 – 11/6
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
